JetBlue Airways Corporation vs 22nd Century Group Inc — how do they compare? JetBlue Airways Corporation trades at $5.34 (market cap $2.03B), while 22nd Century Group Inc trades at $4.25 (market cap $1.49M). The key difference: JetBlue Airways Corporation is far larger — about 1362.4× 22nd Century Group Inc's market cap. Which is the better fit depends on your goals.
| JBLU | XXII | |
|---|---|---|
Market Cap | $2.03B | $1.49M |
Sector | Industrials | Technology |
52-Week High | $6.46 | $1.07K |
52-Week Low | $4.03 | $3.90 |
Enterprise Value | $9.19B | -$6.74M |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XXII trades at $4.32, down 0.23% with bearish technical signals. The company shows negative profitability with -65.76% net income margin and -130.19% ROE, though valuation ratios appear low with P/S of 0.03. Recent corporate actions include a 20:1 reverse stock split in June 2026. The company is expanding VLN product distribution in key markets including California and New York, supported by positive FDA regulatory developments.
While analyst consensus is 75% buy-rated, fundamental challenges persist with consistent revenue declines and negative cash flow from operations. Investment opportunity lies in successful VLN brand expansion and regulatory approvals, but risks include ongoing losses, competitive tobacco market pressures, and execution uncertainty in scaling reduced-nicotine products.
Trailing returns across standard periods
Latest headlines on both assets
JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It carries over millions of customers with an average of more than 1,000 daily flights and served approximately 99 destinations in the United States, the Caribbean, and Latin America. The company currently operates Airbus A321, Airbus A320, and Embraer E190 aircraft types.
Read more on JBLU →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →